Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug

Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.

Pharma stocks, firms, earnings

Shares of select pharmaceutical companies rallied up to 8 per cent on the BSE in Monday’s intra-day trade after several companies signed voluntary license for Pfizer Inc's Covid-19 oral treatment–

Also Read

Sun Pharma Q3 results: Net profit rises 11% to Rs 2,058.8 crore

Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high

Strong product pipeline, valuations keep street positive on Aurobindo

N Govindarajan steps down as Aurobindo Pharma managing director

Laurus Labs up 8% in two days on purchase orders from global pharma company

Future Group shares hit record lows; Future Retail tanks 16% in two days

Accenture Q2FY22 results and what it means for the Indian IT sector

Greaves Cotton rises 6%; rallies 15% in two days on heavy volumes

IT shares gain on Accenture's strong Q2 show, higher revenue guidance

Dodla Dairy to acquire Sri Krishna Milks for Rs 50 crore; stock surges 19%

First Published: Mar 21 2022 | 12:29 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to